Pivotal phase II data presented for murlentamab in metastatic colorectal adenocarcinoma July 10, 2019
Trovagene initiates enrollment in phase Ib/II study of onvansertib in mCRC with KRAS mutation July 10, 2019
EIP Pharma initiates phase II study of neflamapimod for the treatment of cognitive deficits in HD July 10, 2019
Preliminary interim data presented from phase I trials of Celyad's CYAD-01 and CYAD-101 July 10, 2019
RSS